Multiple interacting gene products may influence susceptibility to malignant hyperthermia

被引:52
|
作者
Robinson, RL [1 ]
Curran, JL
Ellis, FR
Halsall, PJ
Hall, WJ
Hopkins, PM
Iles, DE
West, SP
Shaw, MA
机构
[1] St James Univ Hosp, Acad Unit Anaesthesia, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Leeds, St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England
[4] No Genet Serv, Mol Genet Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
10.1046/j.1469-1809.2000.6440307.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Malignant hyperthermia (MH) is a potentially lethal disorder triggered in susceptible individuals on exposure to common anaesthetic agents. Crises reflect the consequences of disturbed skeletal muscle calcium homeostasis. MH is an autosomal dominant, genetically heterogeneous trait. Defects in a single major gene have been assumed to determine susceptibility status in individual families. However, in some pedigrees phenotypic and genotypic data are discordant. One explanation, in contrast to the current genetic model, is that susceptibility is dependent upon the effects of more than one gene. Using the transmission disequilibrium test we assessed the involvement of 8 MH candidate loci (RYR1, CACNA1S, CACNA2D1, MHS4 at 3q13.1, MHS6 at 5p, LIPE, DM1, dystrophin) by analysis of data from 130 MH nuclear families. Results suggested that variations in more than one gene may influence MH susceptibility in single families.
引用
收藏
页码:307 / 320
页数:14
相关论文
共 50 条
  • [1] Several interacting genes influence the malignant hyperthermia phenotype
    Rachel Robinson
    Philip Hopkins
    Antonella Carsana
    Hermann Gilly
    Jane Halsall
    Luc Heytens
    Gunilla Islander
    Karin Jurkat-Rott
    Clemens Müller
    Marie-Anne Shaw
    [J]. Human Genetics, 2003, 112 : 217 - 218
  • [2] Several interacting genes influence the malignant hyperthermia phenotype
    Robinson, R
    Hopkins, P
    Carsana, A
    Gilly, H
    Halsall, J
    Heytens, L
    Islander, G
    Jurkat-Rott, K
    Müller, C
    Shaw, MA
    [J]. HUMAN GENETICS, 2003, 112 (02) : 217 - 218
  • [3] The ryanodine contracture test may help diagnose susceptibility to malignant hyperthermia
    Reuter, DA
    Anetseder, M
    Müller, R
    Roewer, N
    Hartung, EJ
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2003, 50 (07): : 643 - 648
  • [4] RYANODINE RECEPTOR GENE POINT MUTATION AND MALIGNANT HYPERTHERMIA SUSCEPTIBILITY
    MORONI, I
    GONANO, EF
    COMI, GP
    TEGAZZIN, V
    PRELLE, A
    BORDONI, A
    BRESOLIN, N
    SCARLATO, G
    [J]. JOURNAL OF NEUROLOGY, 1995, 242 (03) : 127 - 133
  • [5] Genetics and Susceptibility to Malignant Hyperthermia
    Anderson-Pompa, Kathryn
    Foster, April
    Parker, Lee
    Wilks, Lance
    Cheek, Dennis J.
    [J]. CRITICAL CARE NURSE, 2008, 28 (06) : 32 - 36
  • [6] The Myotonias and Susceptibility to Malignant Hyperthermia
    Parness, Jerome
    Bandschapp, Oliver
    Girard, Thierry
    [J]. ANESTHESIA AND ANALGESIA, 2009, 109 (04): : 1054 - 1064
  • [7] Predicting malignant hyperthermia susceptibility
    Allen, G
    [J]. ANESTHESIOLOGY, 1998, 89 (03) : 797 - 798
  • [8] Propofol and malignant hyperthermia susceptibility
    Pollock, AN
    McKenzie, AJ
    Hodges, M
    Snoeck, MMJ
    [J]. ANAESTHESIA AND INTENSIVE CARE, 1997, 25 (05) : 583 - 585
  • [9] DETECTING SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA
    ELLIS, FR
    [J]. BRITISH MEDICAL JOURNAL, 1992, 304 (6830): : 791 - 792
  • [10] SCREENING FOR MALIGNANT HYPERTHERMIA SUSCEPTIBILITY
    ANDERSON, IL
    RAWSTRON, RE
    DUNLOP, DJ
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1980, 91 (661) : 417 - 419